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We had reported earlier the enhanced phosphorylation of a 38-kilodalton protein (p38) in rat liver plasma
membrane by ras proteins. Now we show that glucagon increased the phosphorylation of the same protein. The
nature and site(s) of phosphorylation were the same as those for the ras proteins. Both ATP and GTP could
donate phosphate for the phosphorylation of p38. The stimulation of p38 phosphorylation by glucagon was
guanine nucleotide dependent. This observation, together with our data on the stimulation of p38 phosphor-
ylation by AIF4 , suggest the involvement of G proteins in the reaction. We also showed that glucagon
stimulates the phosphorylation of p38 in vivo.
The ubiquitous occurrence of the ras family of genes in
eucaryotic organisms (2) and evidence for their expression in
a number of human (9, 36, 38, 41) and animal (1, 2, 5, 19, 45)
tumors as well as normal tissues (13, 32, 42) has resulted in
considerable recent interest in the study of ras oncogenes.
Although the ras proteins are known to bind GTP and GDP
and have GTPase activity (16, 31), the biological function of
ras proteins remains unknown. GTPase-activating proteins
have been shown to interact with ras proteins (31), but the
exact role of ras in signal transduction still remains to be
understood (24). Since phosphorylation is known to play a
key role in signal transduction (7, 10, 22, 34), we had
investigated the effect of ras proteins on the phosphorylation
of plasma membrane proteins from rat liver and had reported
increased phosphorylation of a 38-kilodalton protein (p38)
present in the preparations (20).
The ras proteins used in our experiments contained bound
GDP (37). We had observed also (20) that GDP stimulates
the phosphorylation of p38, although to a lesser extent
compared with the stimulation observed in the presence of
ras proteins. These observations suggested possible involve-
ment of guanine nucleotides in the phosphorylation of p38. It
was therefore of interest to check whether any of the factors
which act on rat liver cells in a guanine nucleotide-dependent
manner affected the phosphorylation of p38. We report here
the effect of glucagon on the phosphorylation of p38 and
show for the first time that the ras gene product and glucagon
stimulate the phosphorylation of the target protein (p38) at
an identical site(s).
MATERIALS AND METHODS
ras protein. The ras protein EC (normal human c-Ha-ras-1
with Gly-12, Ala-59, and Gln-61) expressed in Escherichia
coli and purified to homogeneity (15) was provided by J. B.
Gibbs of Merck Sharp & Dohme Research Laboratories.
Plasma membrane preparations. Plasma membranes were
isolated from livers of male Wistar rats by the procedure of
Lesko et al. (27). This method yields highly purified plasma
membrane preparations as judged by marker enzyme assays
(40).
Phosphorylation reactions. The in vitro phosphorylation
reactions were performed as follows. To a 100-pl reaction
mixture, 0.21 M D-mannitol, 0.07 M sucrose, 1 mM HEPES
* Corresponding author.
(N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) at
pH 7.5, 2.5 mM MgCl2, and 20 ,ug of liver plasma membranes
were added. The reactions with or without glucagon or ras
(EC) were started by adding 10 ,uCi of [-y-32P]ATP (3,000
Ci/mmol), and after incubation (at 30°C) for 5 min, they were
terminated by the addition of 50 RI of sample buffer (to give
a final concentration of 0.0625 M Tris [pH 6.8], 2% sodium
dodecyl sulfate, 10% glycerol, 5% 2-mercaptoethanol, and
0.001% bromophenol blue). In the experiments involving
labeled GTP, the reactions were started with 1 ,uM [-_32P]
GTP (>10 mCi/mmol; Amersham International plc., Buck-
inghamshire, England). The reaction mixtures, after the
addition of sample buffer, were boiled at 100°C and analyzed
by discontinuous sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (26) with 10% acrylamide in the resolving
gel. After electrophoresis, the gels were treated with a
solution containing 10% isopropyl alcohol and 10 mM so-
dium pyrophosphate, washed several times with the same
solution, dried, and autoradiographed. The acid lability of
the phosphate moieties was checked by treating the gels with
a solution containing 15% (vol/vol) acetic acid and 15%
(vol/vol) methanol. The relative intensities were measured
by using a soft laser scanning densitometer (Biomed Instru-
ments, Inc., Fullerton, Calif.), and quantification was done
as described previously (29).
The stimulation by AIF4- was done by the method of
Sternweis and Gilman (43). The liver plasma membrane was
incubated with 20 puM AlCl3 plus 5 mM NaF for 50 min at
20°C alone or in combination with either GDP or ras before
phosphorylation.
Peptide mapping. After electrophoretic separation and
autoradiography, the phosphorylated p38 band was excised
from the dried gel, cut into small pieces, and subjected to
peptide mapping with Staphylococcus aureus V8 protease
(Boehringer GmbH, Mannheim, Federal Republic of Ger-
many) as described by Cleveland et al. (6). The resolving gel
had 15% acrylamide. After electrophoresis, the gels were
fixed in a solution containing 10% isopropyl alcohol and 10
mM sodium pyrophosphate, washed several times with the
same solution, dried, and autoradiographed.
Antiserum to p38. Pure p38 was obtained by electroelution
(21) and was dissolved in phosphate-buffered saline and
emulsified in complete Freund adjuvant and injected (100 ,ug
of protein) intradermally into multiple sites on the back of a
New Zealand White rabbit. Booster doses were given in
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FIG. 1. Enhancement of phosphorylation of p38 by glucagon (20 ,ug/ml). Phosphorylation reactions were performed as described in the
text. (A) Lanes: 1, control; 2, glucagon; 3, glucagon plus 10 nM GTP; 4, glucagon plus 100 nM GTP; 5, glucagon plus 500 nM GTP; 6, ras
(EC) (20 ,ug/ml). Exposure time was 12 h at -70°C with intensifying screens. (B) Autoradiography after acid treatment of the gel. Lanes and
exposure conditions are the same as in panel A.
incomplete Freund adjuvant. Test bleedings were monitored
by the Ouchterlony double-diffusion technique (35).
Immunoprecipitation. The products of in vitro phosphor-
ylation were immunoprecipitated as follows. Phosphoryla-
tion reactions were done as described above. After incuba-
tion for 5 min at 30°C, reactions were terminated by the
addition of 50 ,ul of 3x immunoprecipitation buffer (lx
buffer is 10 mM Tris [pH 7.4], 1 mM phenylmethylsulfonyl
fluoride, 1% Nonidet P-40, 2 mM EDTA, and 0.15 M NaCI)
and rapid cooling in crushed ice. Immunoprecipitation reac-
tions were performed essentially by the procedure described
by Davis et al. (8). After immunoprecipitation followed by
electrophoresis, the gels were fixed and washed with a
solution containing 10%o isopropyl alcohol and 10 mM so-
dium pyrophosphate before drying and autoradiography.
In vivo phosphorylation. Liver cells were grown in suspen-
sion (3, 14) in phosphate-free Dulbecco modified Eagle
medium (106 cells per ml containing 1 mCi of carrier-free 32p
per ml). The cells were incubated at 37°C for 90 min to label
the intracellular nucleotides. At the end of the incubation,
glucagon (20 ,ug/ml) was added and the cells were further
incubated for 5 min. The incubation was terminated by rapid
cooling in crushed ice, and the cells were immediately
collected by centrifugation and lysed in immunoprecipitation
buffer and the immunoprecipitation experiments were per-
formed as described above.
Other procedures. Protein was estimated by the method of
Lowry et al. (28). Protein bands from gels were transferred
to nitrocellulose papers by the method described by Towbin
et al. (47), and the blots were probed with antibodies by the
procedure described by Gould et al. (18).
RESULTS
Stimulation of p38 phosphorylation by glucagon. We stud-
ied the effect of glucagon on phosphorylation in the presence
or absence of GTP or GDP in the reaction mixtures. Gluca-
gon stimulated the phosphorylation of p38 markedly in the
presence of GTP (Fig. 1A and 2). There was no increase in
phosphorylation of p38 in the absence ofGTP (Fig. 1A). The
stimulation of phosphorylation brought about by a combina-
tion of GTP and glucagon was higher than the stimulation
obtained with GTP alone (Fig. 2). When GDP was used in
place of GTP, GDP also stimulated the phosphorylation,
albeit to a lesser extent than that observed with GTP (Fig. 2).
Nature and sites of p38 phosphorylation. We studied the
phosphorylation of p38 in the presence of glucagon or ras
(EC) in detail. The electrophoretic mobility of p38 phosphor-
ylated in the presence of ras or glucagon was found to be the
same (Fig. 1A). When we checked for the lability of the
phosphate moiety by subjecting the gels to treatment with
15% acetic acid (see Materials and Methods), the phosphate
moiety was completely removed (Fig. 1B). Also, we ob-
served that the phosphate moiety on p38 tends to be stable in
alkali at 55°C (1 M KOH for 1 h). However, at higher
temperatures or with longer incubation time, the phosphate
was labile (unpublished data), indicating that the products of
p38 phosphorylation perhaps involved acyl phosphates (12).
Further, we compared the sites of phosphorylation by pep-
tide mapping (6). The results presented in Fig. 3 show
identical peptides of p38 phosphorylated in the presence of
ras or glucagon.
GTP can be a phosphate donor for p38 phosphorylation.
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FIG. 2. Extent of enhancement of phosphorylation of p38 with
GDP (A), GDP plus glucagon (A), GTP (0), and GTP plus glucagon
(0). Phosphorylation reactions were performed as described in the
text. The intensity of phosphorylation of p38 in the control sample
was taken as unity.
Initially, we used ATP as the phosphate donor in experi-
ments done to study the stimulation of p38 phosphorylation
with glucagon. Since the presence of a guanine nucleotide
was obligatory in the reaction mixtures, it was of interest to
check whether GTP could be used instead of ATP in the
phosphorylation reactions. We used 1 ,uM [y-32P]GTP (>10
mCi/mmol) without any cold GTP for these reactions. GTP
could donate phosphate for p38 phosphorylation. Also, ras
and glucagon could enhance phosphorylation of p38 under
these conditions as well (Fig. 4A). There exists a theoretical
possibility that GTP donated its terminal phosphate to ADP
and the ATP thus generated was the phosphate donor. To
rule this out, we used [_y-32P]GTP in the presence of a 10-
fold excess of cold GTP or GppNHp. Under these condi-
tions, the incorporation of phosphate into p38 was almost
totally abolished (data not shown).
Having ascertained that GTP can indeed be a phosphate
donor, we did experiments to check whether ATP and GTP
donated phosphate via the same reaction. The phosphate
incorporated into p38 from 32P-labeled GTP was also acid
labile (Fig. 4B). Further, the comparative peptide maps of
p38 phosphorylated with 32P-labeled ATP and 32P-labeled
GTP showed that the phosphorylation occurred on identical
sites (Fig. 5). We determined the apparent Km for each
nucleotide. Cold GDP or GTP (500 nM) was included in the
experiments involving labeled ATP, since the presence of
guanine nucleotides is obligatory for p38 phosphorylation.
ATP alone did not stimulate p38 phosphorylation in the
concentration range of 1 nM to 100 ,uM. The apparent Km for
ATP was 35 nM and that for GTP was 6 ,M. In competition
experiments in the presence of cold GTP and 32P-labeled
ATP or cold ATP and 32P-labeled GTP, each nucleotide
inhibited the incorporation of label into p38 from the other.
The incorporation of 32p into p38 from labeled ATP (30 nM)
was completely abolished at 10 ,uM cold GTP and was
FIG. 3. Peptide mapping of p38. After autoradiography, the p38
band was cut out and the peptide mapping was performed with 5 jig
of V8 protease. Lanes: 1, glucagon plus GTP (500 nM); 2, ras (EC);
3, glucagon plus GDP (500 nM). The position of the phosphorylated
peptide is indicated by an arrow. Molecular size markers (in
kilodaltons) are indicated on the left. Exposure time was 3 days at
-70°C with intensifying screens.
slightly lowered at 5 ,uM GTP. On the other hand, cold ATP
(highly pure, prepared by phosphorylation of adenosine;
Sigma Chemical Co., St. Louis, Mo.) abolished incorpora-
tion of the label into p38 from 32P-labeled GTP (1 p.M)
slightly at 50 nM and completely at 500 nM. These data
indicate that ATP and GTP contribute phosphate for p38
phosphorylation via similar reaction mechanisms, albeit with
different Kms.
Further, we estimated the stoichiometry of in vitro phos-
phorylation. The radioactive phosphate incorporated into
p38 was 0.3 mol/mol of protein with GTP as the phosphate
donor and 0.006 mol/mol of protein when labeled ATP was
used for phosphorylation. These estimations represent the
phosphorylation of p38 at a minimum level of stimulation,
that is, with 1 ,uM 32P-labeled GTP without any stimulant or
with 30 nM 32P-labeled ATP and 500 nM cold GDP. The
values for apparent Km and stoichiometry are to be consid-
ered with the caveat that they were determined by a crude
system, and the estimation of exact values should await the
purification of the p38 phosphorylation system.
Stimulation of p38 phosphorylation by AIF4-. The results
of experiments on phosphorylation of p38 showed that
glucagon, whose action in liver cells is known to be mediated
by G proteins (33), stimulated p38 phosphorylation. This
stimulation required guanine nucleotides. The combination
of glucagon with the guanine nucleotides was much more
effective than the guanine nucleotide alone. Also, GTP
analogs such as GppNHp stimulated p38 phosphorylation
(data not shown). These are hallmarks of G-protein involve-
ment in any biological process (17). We used another crite-
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FIG. 4. Phosphorylation of p38 with GTP as the phosphate
donor. Phosphorylation reactions were performed as described in
the text with 1 jiM [-y-32P]GTP (>10 mCi/mmol). (A) Lanes: 1,
control; 2, glucagon (20 jLg/ml); 3, ras (EC) (20 jig/ml). Exposure
time was 12 h at -70°C with intensifying screens. (B) Gel treated
with acid before autoradiography. Lanes and exposure conditions
are the same as in panel A.
rion to ascertain the involvement of G protein(s) (17),
namely, the stimulation of phosphorylation by A1F4j. AlF4-
can activate G proteins directly without the involvement of a
receptor (17). A1F4- has been shown to bind to GDP, and
this complex acts like GTP. AlF4- when bound with GDP
behaves like the gamma phosphate of GTP (4).
When we used AlF4- in our system, the combination of
GDP and A1F4- stimulated the phosphorylation of p38
considerably (Table 1). This effect was more than that
observed with GDP alone. Table 1 shows this effect at 1 ,uM
GDP (1 ,uM GDP was used because 20 ,ug of ras per ml has
approximately same amount of bound GDP, see below). We
also checked this effect at 0.5 and 2.5 puM GDP. The same
results were obtained in those cases as well (data not
shown). Also, the results of our experiments showed that
AlF4j in combination with GDP-bound ras was quite effec-
tive in stimulating p38 phosphorylation. This effect was more
than the effect of ras alone (Table 1). AIF4- alone did not
have any appreciable effect on p38 phosphorylation, show-
ing thereby that it was not due to inhibition of phosphatases
or other such effects.
Antiserum to p38. To study the phosphorylation of p38 in
vivo, we needed antibodies specific to p38. We electroeluted
the p38 band from Coomassie blue-stained gels (21) and
raised antibodies against p38 as described above. When the
Ouchterlony test showed positive results with pure p38, we
checked the specificity of the antibodies by Western blots
(immunoblots) (18) of liver plasma membrane of total liver
extract. Only p38 was recognized at various dilutions of the
antibody (data not shown).
FIG. 5. Comparative peptide mapping of p38 phosphorylated
with labeled GTP (lane 1) or ATP (lane 2). The phosphorylation
reactions were performed as described in the text with [y-32P]GTP
or [y-32P]ATP. The p38 band in each case was subjected to peptide
mapping with 2 ,ug of V8 protease. Approximately equal counts
were loaded in both the lanes. Exposure time was 5 days at -70°C
with intensifying screens. Molecular size markers (in kilodaltons)
are indicated on the left. The major phosphopeptide is indicated by
an arrow.
To test whether the antibodies recognized the native and
also the phosphorylated forms of p38, we did immunopre-
cipitations as described in Materials and Methods. At all
dilutions, the p38 band was the most prominent one (Fig. 6).
At 1:100 dilution, p38 was the only protein that was immu-
noprecipitated. With preimmune serum, no p38 precipitation
was observed (even after long exposure). To make sure that
the protein immunoprecipitated was indeed p38, we electro-
phoresed the products of in vitro phosphorylation reactions
on the same gel. The electrophoretic mobility of immuno-
precipitated phosphoprotein was the same as that of the
protein phosphorylated in vitro (Fig. 6, lanes 5, 6, and 7). It
can also be seen from Fig. 6 that although there were many
phosphoproteins in the starting material, the antibodies
precipitated only p38. Taking all these data together, one
TABLE 1. Effect of AlF4- on phosphorylation of p38a
Extent of en-
hancement in
Addition phosphoryla-
tion of p38
(% of control)
None ........................ 100
AlF4- 185
GDP (1 iM)........................................ 450
GDP (1 jLM) + A1F4 ........................................ 870
ras (EC) (20 ,ug/ml) .......................... 1,175
ras (EC) + A1F4- (20p.g/ml) .................... 1,762
a The experiment was performed as described in the text. The intensity of
the p38 band when no addition was made (control) was taken as 100.
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FIG. 6. Immunoprecipitation of phosphorylated p38 with antise-
rum against p38. The experiments were performed as described in
the text. Lane 1, Preimmune serum; lane 2, 1:100 dilution of anti-p38
serum without normal rabbit serum in the first step; lane 3, 1:40
dilution of anti-p38 serum with normal rabbit serum in the first step;
lane 4, 1:100 dilution of anti-p38 serum with normal rabbit serum in
the first step. Lanes 5 to 7 show the starting material for immuno-
precipitation, i.e., the in vitro phosphorylation products. Lane 5,
Control; lanes 6 and 7, ras (50 ,ug/ml). Exposure time: lanes 1 to 4,
3 days at -70°C with intensifying screens; lanes 5 to 7, 12 h at -70°C
with intensifying screens.
could be reasonably certain that the antibodies raised were
indeed against p38; they were monospecific and they recog-
nized the native and phosphorylated forms of p38.
Stimulation of p38 phosphorylation by glucagon in vivo. To
check whether glucagon stimulated p38-phosphorylation in
vivo, we grew liver cells in phosphate-free Dulbecco modi-
fied Eagle medium in the presence of 32p to label the
intracellular nucleotides. At the end of the incubation,
glucagon (20 ,ug/ml) was added, and after a further 5- min
incubation, the cells were lysed and immunoprecipitated.
Immunoprecipitations were done with validated serum
against p38 (see above). p38 phosphorylation was stimulated
at least two- to threefold by glucagon under these conditions
(Fig. 7). To recognize the p38 band unambiguously, we
loaded the products of in vitro phosphorylation reactions on
the same gel along with the immunoprecipitated samples
(Fig. 7, lanes 3 and 4).
To ascertain the nature of p38 phosphorylation which
occurred in vivo, the gels after electrophoresis of immuno-
precipitated samples were subjected to acid treatment before
autoradiography. They p38 bands were excised from the
acid-treated and untreated gels and counted for radioactiv-
ity. The phosphate moiety of p38 phosphorylated in vivo was
acid labile just as for in vitro phosphorylation (Table 2).
Further, when the p38 bands phosphorylated by stimula-
tion with glucagon in vitro and in vivo were subjected to
a comparative one-dimensional peptide mapping, we ob-
FIG. 7. In vivo stimulation of p38 phosphorylation by glucagon.
Metabolic labeling with 32P and immunoprecipitation with anti-p38
serum (1:40 dilution) were performed as described in the text. Lane
1, Control; lane 2, glucagon (20 ,ug/ml). Lanes 3 (control) and 4
(glucagon [20 ,ug/ml] plus 500 nM GTP) correspond to products of in
vitro phosphorylation. Exposure time: lanes 1 and 2, 7 days at
-70°C; lanes 3 and 4, 6 h at -70°C; both with intensifying screens.
served that the phosphorylation occurred on the same site(s)
(Fig. 8).
DISCUSSION
We established that glucagon stimulates the phosphoryla-
tion of p38 in vitro and in vivo. The phosphorylation in p38
in the presence of glucagon appeared identical with the
phosphorylation taking place in the presence of ras proteins.
Further, we showed that the phosphorylation of p38 stimu-
lated by glucagon in vitro and in vivo occurs on the same
site(s) and is of the same nature.
The enhancement of phosphorylation brought about by
glucagon observed in vitro required the presence of guanine
nucleotides. For reactions done with ras proteins, guanine
nucleotides are already available in the bound form. The
dependence of the phosphorylation reactions on guanine
nucleotides suggests the involvement of G proteins in the
phosphorylation of p38. In reaction pathways mediated by G
proteins, the active form of the proteins is believed to be the
GTP-bound molecule (17, 44). In the present experiments,
glucagon stimulated the phosphorylation of p38 in the pres-
ence of both GTP and GDP. Since we used plasma mem-
brane preparations for phosphorylation reactions, it is quite
TABLE 2. Acid lability of p38 phosphorylated in vivo
Description 32p countsa
Untreated .......................................... 100
Acid treated ............ .............................. 10
Background.......................................... 9
a The gels were dried and autoradiographed with or without acid treatment.
The p38 band in each case was excised from the dried gels, and Cerenkov
counts were obtained.
MOL. CELL. BIOL.
GLUCAGON- AND ras-ENHANCED PHOSPHORYLATION OF p38 2473
1 2
94-
67-
43-
30-
20-
1 -
FIG. 8. Comparative peptide mapping of p38 phosphorylated in
vitro (lane 1) and in vivo (lane 2). The experiment was performed as
described in the text with 2 ,ug of V8 protease in each lane. Exposure
time was 15 days at -70°C with intensifying screens. Molecular size
standards (in kilodaltons) are shown on the left. The position of the
phosphorylated peptide is indicated by an arrow.
possible that GTP was generated in the reactions from GDP
by the dinucleotide kinase activity present in the prepara-
tions. This type of conversion of GDP to GTP will also
explain the stimulatory activity of GDP-bound ras proteins.
Observations similar to this have been made for yeast RAS2
proteins (11), the vertebrate adenylyl cyclase system (25),
and G-protein-modulated mitogenesis with prolactin and
interleukin-2 (46). Also, it has recently been demonstrated
that glucagon regulates GDP-to-GTP conversion with subse-
quent activation of a G protein (23). We have also observed
that GDPpS, an analog of GDP which cannot be converted
to GTP, cannot stimulate p38 phosphorylation (unpublished
observation). Another observation which would argue for
the involvement of a G protein is the stimulation of p38
phosphorylation by AlF4-. As we showed (Table 1), AlF4-
in the presence of GDP stimulates the phosphorylation
significantly. Like G proteins, ras proteins also bind GTP
and GDP and have GTPase activity (16, 31). Owing to these
properties and their sequence homology with G proteins, ras
proteins are considered to be similar to the former (2, 17).
Hence, one would expect AlF4j to have the same effect on
ras proteins also. In fact, A1F4- has been used to stimulate
p21 ras in experiments designed to delineate its function
(39). It has been shown with fluorescent GDP analogs that
A1F4- induces conformational changes in the p21 ras mole-
cule (39). Hence, a combination of ras and AlF4j would be
equivalent to using the GTP-bound form of ras. We observed
that the combination of ras with AlF4j stimulated p38
phosphorylation considerably (Table 1). The stimulation of
any reaction by AIF4- has been accepted as one of the
criteria for the involvement ofG proteins (17).
Note that the acid-labile phosphorylation observed under
the conditions of our experiments is novel. This is the first
instance in which phosphorylation of a cellular protein has
been identically stimulated by ras proteins and a peptide
factor. At present, the exact nature of the linkage of the
phosphate moiety is not known. Since it is labile in acid and
also in strong, hot alkali, it is likely to be an acyl phosphate
and probably not phosphohistidine as we thought earlier
(20). The phosphorylation of p38 is likely to be physiologi-
cally significant, considering that the stimulation by gluca-
gon occurs in vivo. We are examining the possible role of G
proteins in p38 phosphorylation and that of phosphorylated
p38 in signal transduction.
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